@dailyanalysts · Tuesday, September 1, 2026 · intraday marks as of 1:23 PM ET (17:23 UTC). Broadcom (AVGO $369.42) reports fiscal Q3 Wednesday, September 2, after the close.
The call: No pre-print position. If Tan RAISES the FY27 AI guide above $100B — buy above $385, target $455, invalidation weekly close < $355. If he HOLDS ">$100B" again — buy the $330–348 flush, target $430, invalidation weekly close < $322.
Why now: AVGO is down ~25% from its June peak while FY27 EPS consensus ROSE from $18.22 to $19.53. The derate already happened; the stock sits exactly on its 200-day (~$369) and outperformed semis today.
The disagreement: Consensus braces for a June redux — flat guide equals punishment. My opinion: a flat guide at $370 is pre-paid pain; the flush is the entry, not the exit, because December is when the raise was always going to come.
The level that changes everything: a weekly close below $322. There, the market is repricing FY27 below $100 billion and every long thesis in this name is dead.
The only line that matters Wednesday night is whether CEO Hock Tan moves the fiscal-2027 AI revenue anchor off "in excess of $100 billion." Everything else on the tape is choreography.
Recall June 3: Broadcom beat adjusted EPS ($2.44 vs $2.40), missed revenue by two-tenths of a percent ($22.19B vs $22.27B), guided Q3 revenue to $29.4B against $28.53B consensus, and said Q3 AI revenue would grow over 200% year-over-year to $16.0 billion. The stock still fell more than 12% the next day (roughly 15% at the intraday worst). CNBC's headline blamed "weak software sales, unchanged AI chip forecast" — but the software miss was a 2% blemish ($7.18B vs $7.32B); the unchanged forecast was the sin. A $250-billion-plus market-value haircut, per the FT's own framing of that day, for one reiterated number.
The setup into tomorrow is different in one crucial way: price. AVGO trades at $369.42, roughly 25% below the early-June intraday peak of $495 (record close $481.57 on June 2), pinned exactly on its 200-day moving average (~$369) — and today, with the Nasdaq 100 down 1.2% on a bond selloff, AVGO is down just 0.25% and holding that line into the print. The options market prices the September 4 weekly $370 straddle for an ~8% move with a 2:1 call/put skew. For context on that skew: MarketChameleon's 12-quarter history says the options market overestimated AVGO's post-earnings move 42% of the time.
There is no "beat" to buy tomorrow; there is only the bridge to 2027. Consensus for Q3 is $29.43–29.44 billion in revenue with adjusted EPS clustering $3.16–$3.24 (moomoo's panel shows GAAP $2.55) — and the $29.4B revenue figure is not a forecast, it is the company's own guidance, verbatim from the "Third Quarter Fiscal Year 2026 Business Outlook" section of the June 3 release. The quarter prints on the company's number unless something broke in August.
Three numbers actually matter tomorrow night:
The arithmetic the guide has to bridge: FY27 ">$100B" requires an average above $25B per quarter — a ~39% step-up from the likely Q4 exit rate (~$18B, my estimate). Morgan Stanley models ~$120B ($30B/quarter). That gap is why "hold" reads as a negative at any price, and why December — the print where Tan set the $100B anchor in the first place — is the structural raise event, not Wednesday.
You are not being asked to pay June's price for tomorrow's risk. The stock is down ~25% from the peak and 4.9% over the past month while the S&P rose; it is up just 7.4% YTD against the S&P's 12.5%. Meanwhile the 44-analyst panel reads 7 Strong Buy / 37 Buy / 4 Hold / 0 Sell, with an average target of $526 — 42% above spot — and FY27 EPS consensus has DRIFTED UP from $18.22 to $19.53 over ninety days, with three upward revisions in the last 30 and zero cuts. Price down a quarter, earnings up 7%: that divergence is the entire opportunity.
The multiple map (my arithmetic on the $19.53 consensus): $370 = 18.9x FY27; the June record close of $481.57 = 24.6x a lower estimate; $348 = 17.8x; $330 = 16.9x; $430 = 22x; $455 = 23.3x. BNP Paribas Exane's street-high $675 is ~34.5x. The Fool's YCharts lens (31x forward on next-twelve-month EPS) says the same thing from a different denominator: near the low end of this year's range. Morgan Stanley's Joseph Moore, in the July 14 note that framed the whole debate, said he was "surprised by the year-to-date underperformance" — AVGO +13% YTD at that point versus the semiconductor ETF's +90%.
Two primary-source footnotes worth more than they appear. First, from the Q2 cash flow statement: Broadcom's repurchase program bought $7.85B of stock in the quarter ended February 1 and just $600M in the quarter ended May 3 — the company's own bid largely left the tape right as the stock peaked. Second, insider activity: no Form 4 sales filed in the 30 days before this print. The June cluster (co-founder Henry Samueli's scheduled sales at $377–388 plus gifts; other executives at $379–401 in early July) is routine in size and above today's price. Neither is a red flag; both belong in the file.
The reason this stock cannot re-rate is that its growth story is one customer's sourcing decisions, and that customer is visibly building alternatives. Morgan Stanley attributes roughly $80 billion of its ~$120 billion FY27 AI estimate to Google-TPU-related revenue. Three fronts, all recent:
The concentration math: at 80% retention (the bull case) the story holds; a slide to 60% share removes roughly $16 billion of FY27 revenue — about 8% of the growth story — and the targets here come down ~10%. The macro leg compounds it: hyperscalers are spending 102% of cloud revenue on capex; UBS cut its 2027 AI industry revenue outlook to $1.3 trillion with hyperscaler capex growth slowing to 25% in 2027 and 6% in 2028, and trimmed its AVGO target to $470 from $485, seeing "modest" Q3 upside and doubting this report "will sway the overarching debate." And the tape pays nothing for patience right now: the 10-year yield is at its highest since January 2025, oil is above $92 after the U.S. struck Iran over the Hormuz attacks, and the market prices roughly two-in-three odds of a September 16 hike.
My opinion: Morgan Stanley's 80% is the right 2027 base case. The operational hurdles are real, and Google itself expanded its Broadcom deal in April — alongside Anthropic — while Meta extended through 2029 on a one-gigawatt commitment, OpenAI's first custom chip is Broadcom-built, and Apple's expanded partnership is valued above $30 billion. Six core customers, per Tan in June. But the direction of share at the edges is one-way; only the pace is uncertain. That is exactly why the flush-buy below carries a $322 invalidation instead of a comfortable one.
My math says owning the print itself is negative expected value; the edge is in the branches. The pre-print EV model (mine, assumptions in Appendix B): ~30% chance of a raise (+8–15%), ~50% hold with a solid Q4 guide (−5 to −12%), ~20% hold with a soft guide (−12 to −18%), under 5% cut. Weighted, that is roughly −4% at $369 — with the 2:1 call skew adding fuel to the unwind branch. The ~8% straddle prices the same binary fairly (options overestimated the move 42% of the last 12 quarters). There is no edge in the coin flip; there is edge in the aftermath.
| Branch A: the raise | Branch B: the hold | |
|---|---|---|
| Trigger | FY27 AI guide raised above $100B (any explicit raise) | ">$100B" reiterated, unchanged |
| Action | Buy strength | No print trade; buy the flush |
| Entry zone | $385–400 (post-print confirmation) | $330–348 limit orders |
| Target | $455 (23.3x FY27E $19.53) | $430 (22x; December print is the raise event) |
| Invalidation | Weekly close < $355 | Weekly close < $322 |
| Timeframe | 1–3 months | 1–3 months |
| Conviction | HIGH (two signals: the raise + price confirmation above $385) | SPECULATIVE, half size (one signal: valuation vs rising estimates) |
This explicitly updates my August call on AVGO. That structure (preferred entry above $385 after the guide; pre-print $355–375 for small event size only; target $455; flat guide = invalidation) treated a hold as a walk-away. The discipline stands — no coin-flip ownership at $369. But the flat-guide outcome has changed character: at $330–348 the market would be paying 17–18x for a rising $19.53 estimate with the December catalyst 14 weeks out. That is an entry, not an exit. If you bought the June flush and are underwater, the honest instruction is the same: Branch B is the add zone, December is the proof date, and $322 weekly is the line where I am wrong.
A. Data snapshot (intraday, Sept 1, 2026, 17:23 UTC / 1:23 PM ET, via market-data handler): AVGO $369.42 (−0.25%, day range $362.00–371.40, prior close $370.34; 52-week $287.17–495.00); SPY $761.70 (−0.70%); QQQ $708.15 (−1.20%); NVDA $218.24 (−1.15%); MRVL $208.47 (−1.51%); GOOGL $335.46 (−1.15%). Macro same day: 10-year yield at its highest since January 2025; WTI at its highest since July after U.S. strikes on Iran following the Hormuz tanker attacks; oil benchmarks above $92. Technical reference set (BigGo, Aug 26): 20-day SMA $393.63, 50-day $387.46, 200-day $369.22; support $356.50, resistance $407.50; April golden cross (50>200) technically intact.
B. Models and arithmetic. (1) Pre-print EV (my opinion): 30% × +11.5% (raise) + 50% × −8% (hold, solid) + 20% × −15% (hold, soft) + 5% × −20% (cut tail, weighted at half) ≈ −4.3%. Load-bearing input: P(raise) = 30%. At P(raise) = 50%, EV flips to roughly +1% and pre-print becomes buyable — that is the dial, and everything else in the model is secondary. Tan's pattern of setting the next-year anchor at December prints (not Q3) is why I set it at 30. (2) Multiple map: price ÷ FY27E $19.53: $330 = 16.9x, $348 = 17.8x, $370 = 18.9x, $430 = 22.0x, $455 = 23.3x, $481.57 = 24.6x, BNP $675 = 34.5x. (3) FY27 bridge: >$100B ÷ 4 = >$25B/qtr average; Q3 actual guide $16.0B; assumed Q4 exit ~$18B (my estimate, not guidance); step-up from exit rate to FY27 average ≈ +39%; Morgan Stanley $120B implies $30B/qtr. (4) Q2 FY26 primary-source table (June 3 release): revenue $22,187M (+48%); semiconductors $15,009M (+79%), infrastructure software $7,178M (+9%); GAAP EPS $1.91, non-GAAP $2.44; adjusted EBITDA $15,244M (69% of revenue); FCF $10,262M (46% of revenue); Q3 guide $29.4B revenue / ~67% non-GAAP operating income / ~68% adjusted EBITDA; cash $19.6B against ~$64.9B total debt, interest expense $776M/qtr; buybacks $600M in Q2 after $7,850M in Q1 (cash flow statement); dividend $0.65/qtr. Hock Tan, in the release: "in Q3 we expect semiconductor revenue from AI to grow over 200 percent year-over-year to $16.0 billion." Bookings context (Q2 call, via TIKR/CNBC): over $30B in AI bookings against $10.8B shipped, visibility to 2028; "the bookings that are coming are not for immediate delivery."
C. Sources. Primary: Broadcom Q2 FY26 results release (June 3, 2026) — outlook and reconciliation sections; SEC EDGAR, AVGO Form 4 filings. Coverage and analysis: CNBC on the June 3 print; TIKR on the selloff and bookings; Motley Fool on post-earnings history; moomoo consensus panel; BigGo on the $60B backlog and technicals. Competition: Morgan Stanley/MediaTek note (July 14); CNBC on the Marvell-Google warrant (Aug 19); Benzinga/Counterpoint on NVHBM (Sept 1). Options and targets: MarketRebellion IV report (Aug 31); MarketChameleon earnings-move history; Investopedia on the UBS trim (Aug 31); KuCoin flash on UBS 2027 AI outlook (Aug 24); 24/7 Wall St on the analyst panel and BNP $675 (Sept 1); 24/7 Wall St on hyperscaler capex (Aug 22). Macro: CNBC on U.S. strikes on Iran; CNBC on the 10-year yield; CNBC on WTI. Customer/deal context: CNBC on the April Google/Anthropic expansion; CNBC on Meta's 1GW commitment.
Opinions are marked as such throughout; everything else is sourced above. Intraday prices carry timestamps in Appendix A. If the print changes any input, the branches reprice — the levels, not the narrative, govern.